Literature DB >> 26998132

A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

Moneeb A K Othman1, Beata Grygalewicz2, Barbara Pienkowska-Grela2, Jolanta Rygier2, Anna Ejduk3, Martina Rincic4, Joana B Melo5, Isabel M Carreira5, Britta Meyer6, Thomas Liehr1.   

Abstract

Acquired copy number changes are common in acute leukemia. They are reported as recurrent amplifications or deletions (del), and may be indicative of involvement of oncogenes or tumor suppressor genes in acquired disease, as well as serving as potential biomarkers for prognosis or as targets for molecular therapy. The present study reported a gain of copy number of 14q13 to 14q32, leading to immunoglobulin heavy chain locus splitting in a young adult female. To the best of our knowledge, this rearrangement has not been previously reported in B-cell acute lymphoblastic leukemia (ALL). Low resolution banding cytogenetics performed at the time of diagnosis revealed a normal karyotype. However, retrospective application of fluorescence in situ hybridization (FISH) banding and locus-specific FISH probes, as well as multiplex ligation-dependent probe amplification and high resolution array-comparative genomic hybridization, revealed previously hidden aberrations. Overall, a karyotype of 46, XX, del(9) (p21.3 p21.3),derivative(14) (pter-> q32.33:: q32.33-> q13 ::q32.33-> qter) was determined. The patient was treated according to the Polish Adult Leukemia Group protocol and achieved complete remission. The results of the present study indicate that a favorable prognosis is associated with these aberrations when the aforementioned treatment is administered.

Entities:  

Keywords:  B-cell acute lymphoblastic leukemia; array-comparative genomic hybridization; cyclin-dependent kinase inhibitor 2A/B deletion; immunoglobulin heavy locus gene rearrangement; molecular cytogenetics

Year:  2016        PMID: 26998132      PMCID: PMC4774591          DOI: 10.3892/ol.2016.4169

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.

Authors:  Guido Marcucci; Claudia D Baldus; Amy S Ruppert; Michael D Radmacher; Krzysztof Mrózek; Susan P Whitman; Jonathan E Kolitz; Colin G Edwards; James W Vardiman; Bayard L Powell; Maria R Baer; Joseph O Moore; Danilo Perrotti; Michael A Caligiuri; Andrew J Carroll; Richard A Larson; Albert de la Chapelle; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2005-11-07       Impact factor: 44.544

2.  MLLT10 and IL3 rearrangement together with a complex four-way translocation and trisomy 4 in a patient with early T-cell precursor acute lymphoblastic leukemia: A case report.

Authors:  Moneeb A K Othman; Joana B Melo; Isabel M Carreira; Martina Rincic; Eyad Alhourani; Kathleen Wilhelm; Bernd Gruhn; Anita Glaser; Thomas Liehr
Journal:  Oncol Rep       Date:  2014-11-25       Impact factor: 3.906

3.  Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.

Authors:  Miyoung Kim; Seon-Hee Yim; Nam-Sun Cho; Seong-Ho Kang; Dae-Hyun Ko; Bora Oh; Tae Young Kim; Hyun Jung Min; Cha Ja She; Hyoung Jin Kang; Hee Yung Shin; Hyo-Sup Ahn; Sung Soo Yoon; Byoung Kook Kim; Hai-Rim Shin; Kyu Sup Han; Han Ik Cho; Dong Soon Lee
Journal:  Cancer Genet Cytogenet       Date:  2009-11

4.  Gene expression profiles predict survival and progression of pleural mesothelioma.

Authors:  Harvey I Pass; Zhandong Liu; Anil Wali; Raphael Bueno; Susan Land; Daniel Lott; Fauzia Siddiq; Fulvio Lonardo; Michele Carbone; Sorin Draghici
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

5.  An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

Authors:  E Clappier; M F Auclerc; J Rapion; M Bakkus; A Caye; A Khemiri; C Giroux; L Hernandez; E Kabongo; S Savola; T Leblanc; K Yakouben; G Plat; V Costa; A Ferster; S Girard; O Fenneteau; J M Cayuela; F Sigaux; N Dastugue; S Suciu; Y Benoit; Y Bertrand; J Soulier; H Cavé
Journal:  Leukemia       Date:  2013-09-25       Impact factor: 11.528

6.  Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.

Authors:  Alice E Davidson; Nele Schwarz; Lina Zelinger; Gabriele Stern-Schneider; Amelia Shoemark; Benjamin Spitzbarth; Menachem Gross; Uri Laxer; Jacob Sosna; Panagiotis I Sergouniotis; Naushin H Waseem; Robert Wilson; Richard A Kahn; Vincent Plagnol; Uwe Wolfrum; Eyal Banin; Alison J Hardcastle; Michael E Cheetham; Dror Sharon; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2013-07-11       Impact factor: 11.025

7.  IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.

Authors:  Anthony V Moorman; Claire Schwab; Hannah M Ensor; Lisa J Russell; Heather Morrison; Lisa Jones; Dino Masic; Bella Patel; Jacob M Rowe; Martin Tallman; Anthony H Goldstone; Adele K Fielding; Christine J Harrison
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

Review 8.  Advances in the molecular pathobiology of B-lymphoblastic leukemia.

Authors:  Yi Zhou; M James You; Ken H Young; Pei Lin; Gary Lu; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Hum Pathol       Date:  2012-05-08       Impact factor: 3.466

Review 9.  Pathogenesis and prognostication in acute lymphoblastic leukemia.

Authors:  Tsila Zuckerman; Jacob M Rowe
Journal:  F1000Prime Rep       Date:  2014-07-08

10.  A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.

Authors:  Tim Hon Man Chan; Chi Ho Lin; Lihua Qi; Jing Fei; Yan Li; Kol Jia Yong; Ming Liu; Yangyang Song; Raymond Kwok Kei Chow; Vanessa Hui En Ng; Yun-Fei Yuan; Daniel G Tenen; Xin-Yuan Guan; Leilei Chen
Journal:  Gut       Date:  2013-06-13       Impact factor: 23.059

View more
  1 in total

1.  Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes.

Authors:  Bo Gao; Michael Baudis
Journal:  Front Genet       Date:  2021-05-13       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.